{"id":"W2014399345","doi":"10.1177/095632020701800201","title":"Apricitabine: A Novel Deoxycytidine Analogue Nucleoside Reverse Transcriptase Inhibitor for the Treatment of Nucleoside-Resistant HIV Infection","year":2007,"lang":"en","type":"review","venue":"Antiviral chemistry & chemotherapy","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"ca_institutions":"Boehringer Ingelheim (Canada); McGill University; Jewish General Hospital","funders":"","keywords":"Reverse-transcriptase inhibitor; Pharmacology; Nucleoside Reverse Transcriptase Inhibitor; Emtricitabine; Nucleoside analogue; Nucleoside; Reverse transcriptase; Lamivudine; Deoxycytidine kinase; Didanosine; Resistance mutation; Zalcitabine; Biology; Virology; Deoxycytidine; Chemotherapy; Virus; Biochemistry; RNA","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002902156,0.001062011,0.002472322,0.0002079581,0.000192215,0.0000350118,0.0002020322,0.0005515512,0.0001324956],"category_scores_gemma":[0.00003870023,0.0006793664,0.001882994,0.0007856882,0.0002158146,0.00007994841,0.00001624253,0.0002878629,0.00002180983],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007045132,"about_ca_system_score_gemma":0.0004579104,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00006857642,"about_ca_topic_score_gemma":0.00001303171,"domain_scores_codex":[0.9968051,0.00002769045,0.001286296,0.0008178394,0.0004352473,0.0006278209],"domain_scores_gemma":[0.9978809,0.0003198567,0.0006450199,0.0008052185,0.0001762508,0.0001727136],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001823489,0.006209542,0.0002609233,0.02379612,0.006628526,0.0001203226,0.0007117476,4.922713e-7,0.03810285,0.00003999819,0.01199272,0.9103132],"study_design_scores_gemma":[0.00561719,0.0003679673,0.0000399807,0.004062474,0.003453675,0.00006218082,0.00004151733,0.00001479386,0.05904878,0.000003586588,0.9267457,0.0005421761],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.004144322,0.9879849,0.0005534178,0.0009131012,0.0002433372,0.004297453,0.0008066849,0.0001611884,0.0008955874],"genre_scores_gemma":[0.001436437,0.9828216,0.001564945,0.0001192834,0.0007518517,0.0004028045,0.001371416,0.0002021236,0.01132951],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.914753,"threshold_uncertainty_score":0.9995658,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04955322289353962,"score_gpt":0.3322231562892709,"score_spread":0.2826699333957313,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}